Shun Shimohama

发表

PS-54-7 Deletion and point mutations in the superoxide dismutase-1 gene in sporadic and familial amyotrophic lateral sclerosis

Hiroshi Hasegawa, Jun Kimura, Tetsuya Imura, 1995 .

Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases.

Jun Kawamata, Shun Shimohama, S. Shimohama, 2011, Journal of Alzheimer's disease : JAD.

Dopamine is involved in selectivity of dopaminergic neuronal death by rotenone

Yasuhiko Izumi, Shuji Kaneko, Akinori Akaike, 2003, Neuroreport.

Estradiol protects mesencephalic dopaminergic neurons from oxidative stress‐induced neuronal death

Akinori Akaike, Shun Shimohama, S. Shimohama, 1998, Journal of neuroscience research.

Heat‐shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn superoxide dismutase: clues to a possible strategy for treating ALS

Jun Kawamata, Shun Shimohama, Koji Yamanaka, 2007, Journal of neurochemistry.

Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.

Yasuhiko Izumi, Akinori Akaike, Toshiaki Kume, 2010, Biochemical and biophysical research communications.

Gluten sensitivity in Japanese patients with adult-onset cerebellar ataxia.

Hidekazu Tomimoto, Shun Shimohama, Makoto Matsui, 2006, Internal medicine.

Mitochondrial abnormalities in Alzheimer disease

Robert B. Petersen, George Perry, Shun Shimohama, 2000, Neurobiology of Aging.

Possible involvement of both mitochondria- and endoplasmic reticulum-dependent caspase pathways in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells

Shun Shimohama, Y. Kitamura, T. Taniguchi, 2002, Neuroscience Letters.

Alteration of transcription factors NF-κB and STAT1 in Alzheimer's disease brains

Shun Shimohama, Takashi Ota, Y. Kitamura, 1997, Neuroscience Letters.

Inferior Temporal Lobe Atrophy and APOE Genotypes in Alzheimer’s Disease

Jun Kawamata, Shun Shimohama, Seigo Tanaka, 1998, Dementia and Geriatric Cognitive Disorders.

Proteasome Mediates Dopaminergic Neuronal Degeneration, and Its Inhibition Causes α-Synuclein Inclusions*

Hiroshi Shibasaki, Yasuhiko Izumi, Akinori Akaike, 2004, Journal of Biological Chemistry.

Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.

Shun Shimohama, S. Shimohama, 2009, Biological & pharmaceutical bulletin.

Estradiol protects dopaminergic neurons in a MPP+Parkinson’s disease model

Akinori Akaike, Shun Shimohama, S. Shimohama, 2002, Neuropharmacology.

PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson’s disease rat model

Kazuyuki Takata, Shun Shimohama, Takashi Yanagida, 2006, Neurobiology of Disease.

Protein trafficking and Alzheimer's disease.

Shun Shimohama, S. Shimohama, Kengo Uemura, 2004, Current Alzheimer research.

Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4‐phenylbutyrate, a chemical chaperone

Kazuyuki Takata, Shun Shimohama, Takashi Yanagida, 2007, Journal of neurochemistry.